4//SEC Filing
Bain Capital Life Sciences Fund III, L.P. 4
Accession 0000950170-25-107981
CIK 0001464521other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:00 PM ET
Size
29.4 KB
Accession
0000950170-25-107981
Insider Transaction Report
Form 4
Heartflow, Inc.HTFL
Transactions
- Conversion
Common Stock
2025-08-11$15.20/sh+433,924$6,595,645→ 12,448,158 total(indirect: See footnotes) - Conversion
Common Stock
2025-08-11+12,014,234→ 12,014,234 total(indirect: See footnotes) - Conversion
Series F Preferred Stock
2025-08-11−35,081,564→ 0 total(indirect: See footnotes)→ Common Stock (12,014,234 underlying) - Conversion
Subordinated Convertible Promissory Note
2025-08-11→ 0 total(indirect: See footnotes)Exercise: $15.20Exp: 2029-01-24→ Common Stock (433,924 underlying)
Transactions
- Conversion
Common Stock
2025-08-11$15.20/sh+433,924$6,595,645→ 12,448,158 total(indirect: See footnotes) - Conversion
Common Stock
2025-08-11+12,014,234→ 12,014,234 total(indirect: See footnotes) - Conversion
Series F Preferred Stock
2025-08-11−35,081,564→ 0 total(indirect: See footnotes)→ Common Stock (12,014,234 underlying) - Conversion
Subordinated Convertible Promissory Note
2025-08-11→ 0 total(indirect: See footnotes)Exercise: $15.20Exp: 2029-01-24→ Common Stock (433,924 underlying)
Transactions
- Conversion
Common Stock
2025-08-11+12,014,234→ 12,014,234 total(indirect: See footnotes) - Conversion
Common Stock
2025-08-11$15.20/sh+433,924$6,595,645→ 12,448,158 total(indirect: See footnotes) - Conversion
Series F Preferred Stock
2025-08-11−35,081,564→ 0 total(indirect: See footnotes)→ Common Stock (12,014,234 underlying) - Conversion
Subordinated Convertible Promissory Note
2025-08-11→ 0 total(indirect: See footnotes)Exercise: $15.20Exp: 2029-01-24→ Common Stock (433,924 underlying)
BCLS Fund III Investments GP, LLC
10% Owner
Transactions
- Conversion
Common Stock
2025-08-11+12,014,234→ 12,014,234 total(indirect: See footnotes) - Conversion
Common Stock
2025-08-11$15.20/sh+433,924$6,595,645→ 12,448,158 total(indirect: See footnotes) - Conversion
Subordinated Convertible Promissory Note
2025-08-11→ 0 total(indirect: See footnotes)Exercise: $15.20Exp: 2029-01-24→ Common Stock (433,924 underlying) - Conversion
Series F Preferred Stock
2025-08-11−35,081,564→ 0 total(indirect: See footnotes)→ Common Stock (12,014,234 underlying)
BCLS Fund III Investments, LP
10% Owner
Transactions
- Conversion
Common Stock
2025-08-11$15.20/sh+433,924$6,595,645→ 12,448,158 total(indirect: See footnotes) - Conversion
Subordinated Convertible Promissory Note
2025-08-11→ 0 total(indirect: See footnotes)Exercise: $15.20Exp: 2029-01-24→ Common Stock (433,924 underlying) - Conversion
Series F Preferred Stock
2025-08-11−35,081,564→ 0 total(indirect: See footnotes)→ Common Stock (12,014,234 underlying) - Conversion
Common Stock
2025-08-11+12,014,234→ 12,014,234 total(indirect: See footnotes)
Footnotes (4)
- [F1]Each share of the Issuer's Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 0.342466:1 basis immediately prior to the closing of the Issuer's initial public offering. These securities had no expiration date.
- [F2]The outstanding principal amount of the Subordinated Convertible Promissory note automatically converted into shares of the Issuer's Common Stock upon consummation of the Issuer's initial public offering at a conversion price of 80% of the price per share in the Issuer's initial public offering.
- [F3]Represents securities held directly by BCLS Fund III Investments, LP ("BCLS Fund III Investments").
- [F4]Bain Capital Life Sciences Investors, LLC ("BCLSI") is the manager of Bain Capital Life Sciences III General Partner, LLC ("BCLS Fund III GP"), which is the general partner of Bain Capital Life Sciences Fund III, L.P. ("BCLS Fund III"), which is the managing member of BCLS Fund III Investments GP, LLC ("BCLS Fund III Investments GP"), which is the general partner of BCLS Fund III Investments. As a result, each of BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments. BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Documents
Issuer
Heartflow, Inc.
CIK 0001464521
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001875273
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 4:00 PM ET
- Size
- 29.4 KB